Why Shire plc & Royal Bank Of Scotland Group plc Could Plunge Much Further

Shire plc (LON:SHP) & Royal Bank Of Scotland Group plc (LON:RBS) carry more risk than you may think, argues this Fool.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Shire (LSE: SHP) stock was a pretty straightforward investment until Tuesday 4 August, but has become a less obvious call following the British group’s hostile approach for US biotech rival Baxalta, which values the target at $30bn. 

Elsewhere, Royal Bank of Scotland (LSE: RBS) has always been an attractive restructuring story but has never been an obvious equity investment, to be honest, and now becomes even less appealing to me following the sale of a 5% stake by the UK government. 

The “Shaxalta” Risk

Baxalta has declined to engage in substantive discussions regarding the proposal, Shire said on 4 August — and this is a big headache. 

At $45.23 per Baxalta share, Shire’s offer is fair but will have to go up by 10%, 20% or more if Shire, which needs to bulk up to support its rich trading multiples, is serious about securing these assets. Its R&D pipeline is strong, but inorganic growth is essential to boost value, while becoming a more enticing takeover target itself. 

Investors have sold Shire stock since 4 August because any $30bn+ tie-up will likely bring dilution to its shareholders due to the deal’s financing mix, even though dilution risk could be mitigated by share buybacks that Shire plans to launch at a later stage: earnings per share are expected to “breakeven in year one, with accretion thereafter, supported by a share buyback program,” Shire said. 

Unsurprisingly, Shire’s share price dropped 6% on the day the proposed deal was announced, and hasn’t recovered since. Yet its stock could fall a lot more if recent news, according to which Shire will have to bid over $50 a share to buy Baxalta, is to be trusted. 

This week’s drop was because of an all-stock move, and that could mean hefty dilution if the take-out price sky-rockets, given that Shire can’t use cash because of tax-free distribution of Baxalta,” Jacob Plieth at London-based EP Vantage told me. “Well, ‘Shaxalta’ is a rather strange story,” Mr Plieth concluded. 

What Does This Mean? 

In other words, following the recent spin-off of Baxalta from Baxter, Baxalta shareholders won’t have to pay the taxman for the stock they received from the holding company, but they would have to pay a rather large tax bill if they were to receive cash — any cash — from Shire.

Hence, if a cash offer emerges then Shire’s premium for Baxalta, currently at 36%, will likely go through the roof, simply because part of that cash being offered will have to be used by Baxalta shareholders to pay their tax bill. 

The proposed transaction would be structured as an all-stock transaction to maintain the tax-free nature of Baxalta’s July 1, 2015, spinoff from Baxter. Baxalta shareholders would own approximately 37% of the combined Shire group.”

Given the peculiar nature of the deal, Shire is unlikely to lever up, which could prevent hefty dilution if the price tag goes north of $30bn, although its balance sheet could carry much more debt.

So, Shire will likely have to finance the deal issuing new stock, and lots of it. Then, Baxalta’s shareholders may even end up owning more than 37% of the combined entity, if Shire, as it seems likely, pays over the odds, one way or another. 

While the shares of Shire remain a great investment for the long term in my opinion, short-term volatility is likely to continue to push down their valuation, which would render the acquisition of Baxalta even more expensive than it currently is. 

It’s hard not to share bad feelings about the short-term outlook for RBS, too, which also came under the spotlight this week. 

Pressure Mounts On Royal Bank Of Scotland 

The UK government has decided to cut its losses on the RBS investment, selling a portion of its holding earlier this week at a price that is below the level that was required to recoup the money that it borrowed from the taxpayer in the wake of the credit crunch in 2008. 

RBS is not a bad restructuring story in the UK banking universe, but now that the government has started to sell down stock, its shares look fully priced indeed. In fact, I doubt that the benefit of future private ownership will outweigh the downwards pressure on the stock during the entire divestment process, which will take years — unless private investors smell the opportunity to sneak in. 

Consider that Lloyds, whose financials are stronger, has struggled to deliver meaningful capital appreciation for a long time, and will continue to have problems on this front at least until the UK’s government residual 15% stake isn’t sold. The Treasury now owns more than 70% of RBS’s equity, which says a lot about the risk involved in holding RBS stock over the next three or four years. Meanwhile, legal risk is still alive and well, as recent results showed. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alessandro Pasetti has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Jumbo jet preparing to take off on a runway at sunset
Investing Articles

Down 70%+ since 2020, is IAG’s share price an unmissable bargain?

IAG’s share price is still down around 73% from its pre-Covid level, but with the business performing well last year,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

£17,000 of shares in the FTSE 100 dividend giant can make me £18,874 every year in passive income!

This FTSE 100 dividend superstar has an 8.8% yield with dividends projected to rise. It looks very undervalued to me…

Read more »

Investing Articles

2 top UK growth stocks I’m buying for my Stocks and Shares ISA in July

Looking for UK-listed growth firms to add to a Stocks and Shares ISA? Our writer highlights two he's planning to…

Read more »

artificial intelligence investing algorithms
Investing Articles

This overvalued growth stock makes Nvidia look cheap!

ARM Holdings is a growth stock that’s benefitted from the AI rally. Muhammad Cheema takes a look at whether this…

Read more »

Investing Articles

1 penny stock I’d buy today while it’s 63p

This penny stock's down 70% since last March, yet could be set for a big comeback as the firm rebuilds…

Read more »

Businessman use electronic pen writing rising colorful graph from 2023 to 2024 year of business planning and stock investment growth concept.
Investing Articles

Buying 8,617 Legal & General shares would give me a stunning income of £1,840 a year

Legal & General shares offer one of the highest dividend yields on the entire FTSE 100. Harvey Jones wants to…

Read more »

Man writing 'now' having crossed out 'later', 'tomorrow' and 'next week'
Investing Articles

£25k to invest? Here’s how I’d try to turn that into a second income of £12,578 a year!

If Harvey Jones had a lump sum to invest today he'd go flat out buying top FTSE 100 second income…

Read more »

Union Jack flag in a castle shaped sandcastle on a beautiful beach in brilliant sunshine
Investing Articles

2 lesser-known dividend stocks to consider this summer

Summer is here and global markets could be heading for a period of subdued trading. But our writer thinks there…

Read more »